Texas Oncology-Amarillo Cancer Center

Amarillo, Texas 79124

2 studies enrolling now · 4 studies all time

What they study most

Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Non-small Cell Lung Cancer (NSCLC), Primary Myelofibrosis, Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204) — Recruiting now
• A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201) — Recruiting now
• CemiplimAb Survivorship Epidemiology — Completed
• Connect® Myeloid Disease Registry — Stopped early